Journal
CHEMICAL BIOLOGY & DRUG DESIGN
Volume 88, Issue 5, Pages 724-729Publisher
WILEY
DOI: 10.1111/cbdd.12801
Keywords
4-amino-6-alkyloxy-2-alkylthiopyrimidine derivatives; A(1) adenosine receptor; A(1) AR agonists; A(1) AR efficacy; A(1) AR ligands; non-nucleoside adenosine receptor agonists
Ask authors/readers for more resources
Three 4-amino-6-alkyloxy-2-alkylthiopyrimidine derivatives (4-6) were investigated as potential non-nucleoside agonists at human adenosine receptors (ARs). When tested in competition binding experiments, these compounds exhibited low micromolar affinity (K-i values comprised between 1.2 and 1.9m) for the A(1) AR and no appreciable affinity for the A(2A) and A(3) ARs. Evaluation of their efficacy profiles by measurement of intracellular cAMP levels revealed that 4 and 5 behave as non-nucleoside agonists of the A(1) AR with EC50 values of 0.47 and 0.87m, respectively. No clear concentration-response curves could be instead obtained for 6, probably because this compound modulates one or more additional targets, thus masking the putative effects exerted by its activation of A(1) AR. The three compounds were not able to modulate A(2B) AR-mediated cAMP accumulation induced by the non-selective AR agonist NECA, thus demonstrating no affinity toward this receptor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available